Table 2.

Screening log system implementation outcomes by trial type.

Trial Characteristic (Cancer Types Included in Trials)	Number of Trials in Category (N)	Patients Screened During Trial Open Window Identified as Potentially Eligible by Electronic Screening Log System (N)	Patients with Available Eligible Trial Screened During Trial Open Window Missed by Electronic Screening Log System (Identified on Manual Retrospective Re-Review)) (N if blanks excluded) (N if blanks included)	Patients Screened Prior to Trial Open Window that would be Classified as Eligible if Re-Screened when Trial Opened (N if blanks excluded) (N if blanks included)	KUCC Clinical Research Coordinator Implementation Notes and Feedback on Relevant Electronic Screening Log System Deficiencies
Chemotherapy Only (Ovarian/Fallopian Tube/Peritoneal)	5	0	21 13	113 72	•Platinum-sensitivity status relevant to trial not included in screening log •Number of prior lines of chemotherapy relevant to trial not included in screening log
Radiation Included (Endometrial, Cervical, Vaginal/Vulvar)	2	3	75 70	138 121	•Surgical history relevant to trial not included in screening log •FIGO stage subgroups relevant to trial not included in screening log •Re-screening patients evaluated prior to trial open window unlikely to identify eligible patients given trial focused on finite postoperative adjuvant treatment period
Primary Disease (Endometrial, Cervical, Ovarian/Fallopian Tube/Peritoneal)	4	0	84 78	180 160	•Re-screening patients evaluated prior to trial open window unlikely to identify eligible patients given trial focused on finite postoperative adjuvant treatment period
Recurrent Disease (Ovarian/Fallopian Tube/Peritoneal)	4	0	12 5	77 39	•Platinum-sensitivity status relevant to trial not included in screening log •Number of prior lines of chemotherapy relevant to trial not included in screening log
Histology-Specific (Ovarian/Fallopian Tube/Peritoneal)	3	0	10 8	50 39	•High rates of missing data in Histology column of screening log •Serous histology subtypes (low grade, high grade) relevant to trial not included in screening log